Skip to content
healthcare.dev

ATMEKSI

NDC 69528-701, methocarbamol, suspension, from Rosemont Pharmaceuticals LLC.

Product NDC
69528-701
Status
Listed
Labeler
Rosemont Pharmaceuticals LLC
Dosage form
SUSPENSION
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA219843
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/69528-701 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • METHOCARBAMOL750 mg/5mL

Pharmacologic classes

Centrally-mediated Muscle Relaxation [PE]; Muscle Relaxant [EPC]

Package NDCNDC-11Package
69528-701-0569528070105150 mL in 1 BOTTLE (69528-701-05)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/62de7345-613b-4838-96e5-aceca3cea6b2

Use it

Look up 69528-701 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/69528-701 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 69528-701. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.